Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × oblimersen × 90 days × Clear all

Sponsor

Interventions

Cyclophosphamide 13 pembrolizumab 12 fludarabine phosphate 9 Doxorubicin 9 Brentuximab Vedotin 9 fludarabine 8 Dacarbazine 8 Vinblastine 7 Nivolumab 7 Gemcitabine 7 Specimen Handling 6 Filgrastim 6 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 Granulocyte Colony-Stimulating Factor 5 Bleomycin 5 Radiotherapy 4 Etoposide 4 pegfilgrastim 3 Whole-Body Irradiation 3 Vinorelbine 3 Vincristine 3 Stem Cell Transplantation 3 Prednisone 3 Melphalan 3 Dexamethasone 3 Cisplatin 3 Bendamustine Hydrochloride 3 polatuzumab vedotin 2 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡